- Home
- PRAX vs SLGN Comparison
PRAX vs SLGN Comparison
Compare PRAX & SLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- SLGN
- Stock Information
- Founded
- PRAX 2015
- SLGN 1987
- Country
- PRAX United States
- SLGN United States
- Employees
- PRAX N/A
- SLGN N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- SLGN Containers/Packaging
- Sector
- PRAX Health Care
- SLGN Industrials
- Exchange
- PRAX Nasdaq
- SLGN Nasdaq
- Market Cap
- PRAX 4.0B
- SLGN 4.0B
- IPO Year
- PRAX 2020
- SLGN 1997
- Fundamental
- Price
- PRAX $179.18
- SLGN $38.67
- Analyst Decision
- PRAX Strong Buy
- SLGN Strong Buy
- Analyst Count
- PRAX 12
- SLGN 9
- Target Price
- PRAX $212.42
- SLGN $57.22
- AVG Volume (30 Days)
- PRAX 978.5K
- SLGN 1.6M
- Earning Date
- PRAX 11-05-2025
- SLGN 10-29-2025
- Dividend Yield
- PRAX N/A
- SLGN 2.07%
- EPS Growth
- PRAX N/A
- SLGN 6.68
- EPS
- PRAX N/A
- SLGN 2.94
- Revenue
- PRAX $7,463,000.00
- SLGN $6,425,728,000.00
- Revenue This Year
- PRAX N/A
- SLGN $12.59
- Revenue Next Year
- PRAX $44.43
- SLGN $2.46
- P/E Ratio
- PRAX N/A
- SLGN $13.16
- Revenue Growth
- PRAX 364.98
- SLGN 11.10
- 52 Week Low
- PRAX $26.70
- SLGN $36.15
- 52 Week High
- PRAX $206.71
- SLGN $58.14
- Technical
- Relative Strength Index (RSI)
- PRAX 62.04
- SLGN 38.01
- Support Level
- PRAX $159.74
- SLGN $38.03
- Resistance Level
- PRAX $188.53
- SLGN $39.14
- Average True Range (ATR)
- PRAX 13.41
- SLGN 1.21
- MACD
- PRAX -5.00
- SLGN -0.15
- Stochastic Oscillator
- PRAX 47.30
- SLGN 28.07
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About SLGN Silgan Holdings Inc.
Silgan Holdings manufactures about half of the metal food containers in North America. Its major customers include Campbell Soup, Nestle, and Del Monte. Silgan's other business segments include plastic dispensers and containers for personal and healthcare products and a closures business that manufactures metal and plastic lids and caps.